Pacific Biosciences Of Stock Investor Sentiment

PACB Stock  USD 1.45  0.01  0.68%   
About 66% of Pacific Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Pacific Biosciences of stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pacific Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Pacific Biosciences stock news signals to limit their universe of possible portfolio assets.

Comfort Level 34

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Pacific Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Pacific Biosciences of.

Pacific Historical Sentiment

Although Pacific Biosciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Pacific, such as negative comments on social media and news outlets, may cause fear in the market and push Pacific Biosciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Pacific.
  

Pacific Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Pacific Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pacific Biosciences Historical Investor Sentiment

Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacific Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacific Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pacific Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Pacific Biosciences.
over a year ago at finance.yahoo.com         
PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
Yahoo News
over a year ago at zacks.com         
Merit Medicals New Launch to Expand Its Product Suite
zacks News
over a year ago at news.google.com         
PacBio Announces Complete Computational Workflow for Human ... - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Pacific Biosciences of California, Inc. Receives 13.10 Average Target Price from Analysts
news
over a year ago at zacks.com         
Three Reasons to Add PacBio Stock to Your Portfolio
zacks News
over a year ago at seekingalpha.com         
PacBio files for sale of 8.99M shares by selling stockholders
seekingalpha News
over a year ago at zacks.com         
Charles River Launches LVV-based Gene Therapy Platform
zacks News
over a year ago at thelincolnianonline.com         
Insider Selling Pacific Biosciences of California, Inc. Insider Sells 19,257 Shares of Stock
news
over a year ago at thelincolnianonline.com         
Barclays Cuts Pacific Biosciences of California Price Target to 9.00
news
over a year ago at seekingalpha.com         
Bernstein bullish on Thermo, Revvity, Guardant, PacBio bearish on Illumina
seekingalpha News
over a year ago at thelincolnianonline.com         
Sanford C. Bernstein Begins Coverage on Pacific Biosciences of California
news
over a year ago at thelincolnianonline.com         
Pacific Biosciences of California Stock Rating Reaffirmed by Cantor Fitzgerald
news
over a year ago at news.google.com         
President Of Pacific Biosciences of California Sold 29 percent Of Their Shares - Simply Wall St
Google News at Macroaxis
over a year ago at simplywall.st         
President Of Pacific Biosciences of California Sold 29 percent Of Their Shares
Simply Wall St News at Macroaxis
over a year ago at thelincolnianonline.com         
Pacific Biosciences of California, Inc. Insider Sells 980,061.28 in Stock
news
Far too much social signal, news, headlines, and media speculation about Pacific Biosciences that are available to investors today. That information is available publicly through Pacific media outlets and privately through word of mouth or via Pacific internal channels. However, regardless of the origin, that massive amount of Pacific data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pacific Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pacific Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pacific Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pacific Biosciences alpha.

Pacific Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 25000 shares by Mohr Marshall of Pacific Biosciences at 4.45 subject to Rule 16b-3
12/27/2024
2
Pacific Biosciences of California Stock Rating Upgraded by StockNews.com
01/10/2025
3
Acquisition by Ordonez Kathy of 32179 shares of Pacific Biosciences at 1.65 subject to Rule 16b-3
01/23/2025
4
Oncology NGS Market Research, 2024 2025-2029 Integration with AI and Bioinformatics, Increased Focus on Personalized Medicine, Decentralization of NGS Testing
01/29/2025
5
Clinical Oncology Next-Generation Sequencing Market Research and Forecasts 2023-2024 2034 Use of Comprehensive Genomic Profiling, Regulatory Support, and Reimbu...
02/05/2025
6
Pacific Biosciences of California Inc Q4 2024 Earnings Report Preview What To Expect
02/12/2025
7
How Has Institutional Trading Impacted Pacific Biosciences
02/13/2025
8
Goodyear Tire Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
02/14/2025
9
Disposition of 259909 shares by Henry Christian O of Pacific Biosciences at 1.878 subject to Rule 16b-3
02/18/2025
10
PacBio to Participate in TD Cowens 45th Annual Health Care Conference
02/19/2025
11
Pacific Biosciences of California, Inc. Given Consensus Rating of Moderate Buy by Brokerages
02/24/2025
12
Neurogenomics Market Trends Analysis and Global Forecasts Report 2024-2031 Emerging Markets and Increased Awareness Create Opportunities, Declining Sequencing C...
02/28/2025

Complementary Tools for Pacific Stock analysis

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas